Impact of asynchronous ventricular activation on pro-inflammatory cytokines and oxidative stress in paced patients.
Marketou
M E
ME
Simantirakis
E N
EN
Nikitovic
D
D
Chrysostomakis
S I
SI
Zacharis
E A
EA
Vardas
P E
PE
D002304:Cardiac Pacing, Artificial / Q000379:methods*; D016207:Cytokines / Q000378:metabolism*; D005260:Female; D006327:Heart Block / Q000378:metabolism* / Q000628:therapy; D006352:Heart Ventricles; D006801:Humans; D015850:Interleukin-6 / Q000378:metabolism; D008054:Lipid Peroxides / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D018384:Oxidative Stress / Q000502:physiology*; D012804:Sick Sinus Syndrome / Q000378:metabolism* / Q000628:therapy; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D016207:Cytokines; D015850:Interleukin-6; D008054:Lipid Peroxides; D014409:Tumor Necrosis Factor-alpha